Cargando…
Longitudinal Dynamics of Coagulation and Angiogenesis Markers in Cancer Patients During and After Chemotherapy
Hemostatic parameters have been investigated as molecular determinants of tumor progression. To analyze the dynamics of microparticle-associated tissue factor activity (MPTF), tissue factor antigen (TF-Ag), and angiopоietin-2 (ANG-2) in cancer patients before, during, and after active treatment and...
Autores principales: | Beleva, Elina A., Deneva, Tanya I., Stoencheva, Snezhana S., Grudeva-Popova, Zhanet G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8728769/ https://www.ncbi.nlm.nih.gov/pubmed/34918975 http://dx.doi.org/10.1177/10760296211056637 |
Ejemplares similares
-
Assessment of clinical utility and predictive potential of pre-chemotherapy soluble urokinase plasminogen activator receptor: Observational single center study
por: Beleva, Elina, et al.
Publicado: (2023) -
Prothrombin Time and Coagulation Factor IX as Hemostatic Risk Markers for Legg–
Calvé–Perthes Disease
por: Hernández-Zamora, Edgar, et al.
Publicado: (2023) -
The Association of Coagulation Indicators and Coagulant Agents With 30-Day Mortality of Critical Diabetics
por: Huang, Yingxin, et al.
Publicado: (2021) -
Clinical Significance and Dynamic Change of Coagulation Parameters in
Ischemic Stroke Patients Treated with Intravenous Thrombolysis
por: Li, Guangshuo, et al.
Publicado: (2022) -
Upregulation of Coagulation Factor VIII and Fibrinogen After Pulmonary Endarterectomy in Patients with Chronic Thromboembolic Pulmonary Hypertension
por: Myllylahti, Lasse, et al.
Publicado: (2023)